BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$548M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$418M |
| 3 |
UnitedHealth
UNH
|
+$407M |
| 4 |
GE Aerospace
GE
|
+$376M |
| 5 |
Apple
AAPL
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$852M |
| 2 |
Amazon
AMZN
|
+$805M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$496M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$467M |
| 5 |
Advanced Micro Devices
AMD
|
+$435M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.05% |
| 2 | Consumer Discretionary | 7.18% |
| 3 | Financials | 7.17% |
| 4 | Healthcare | 7.13% |
| 5 | Communication Services | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Garrett Motion
GTX
$5.41B
| $471K | ﹤0.01% |
44,814
+42,255
| +1,651% | +$425K |
|
3202
Wave Life Sciences
WVE
$1.07B
| $471K | ﹤0.01% |
72,459
-161,194
| -69% | -$1.06M |
|
3203
Lloyds Banking Group
LYG
$90.1B
| $470K | ﹤0.01% |
110,532
+22,491
| +26% | +$89.4K |
|
3204
Pacira BioSciences
PCRX
$917M
| $470K | ﹤0.01% |
19,646
-146,874
| -88% | -$3.7M |
|
3205
Protara Therapeutics
TARA
$235M
| $469K | ﹤0.01% |
154,665
+2,759
| +2% | +$9.52K |
|
3206
CALL
Atlassian
TEAM
$41.2B
| $467K | ﹤0.01% |
+23
| New | +$4.79K |
|
3207
Invesco Building & Construction ETF
PKB
$397M
| $466K | ﹤0.01% |
5,800
-9,200
| -61% | -$679K |
|
3208
Adaptive Biotechnologies
ADPT
$3.94B
| $465K | ﹤0.01% |
39,916
+31,255
| +361% | +$284K |
|
3209
First Financial Bancorp
FFBC
$3.61B
| $463K | ﹤0.01% |
19,065
+11,344
| +147% | +$269K |
|
3210
Sabesp
SBS
$16.2B
| $462K | ﹤0.01% |
108,498
+32,465
| +43% | +$126K |
|
3211
Bank of Montreal
BMO
$130B
| $462K | ﹤0.01% |
4,176
+2,109
| +102% | +$213K |
|
3212
Lionsgate Studios
LION
$3.57B
| $462K | ﹤0.01% |
79,499
+76,525
| +2,573% | +$512K |
|
|
EPIX
3213
DELISTED
ESSA Pharma
EPIX
| $461K | ﹤0.01% |
271,195
+35,794
| +15% | +$60.4K |
|
3214
Patrick Industries
PATK
$2.76B
| $461K | ﹤0.01% |
4,991
-61,172
| -92% | -$5.2M |
|
3215
Newell Brands
NWL
$2.66B
| $460K | ﹤0.01% |
85,154
-3,206,479
| -97% | -$17M |
|
|
CNTA
3216
DELISTED
Centessa Pharmaceuticals
CNTA
| $460K | ﹤0.01% |
34,972
+33,854
| +3,028% | +$429K |
|
3217
Zegna
ZGN
$3.69B
| $458K | ﹤0.01% |
53,599
+6,421
| +14% | +$51.8K |
|
3218
KB Financial Group
KB
$42.1B
| $458K | ﹤0.01% |
5,547
-102,264
| -95% | -$6.92M |
|
3219
Ducommun
DCO
$3.13B
| $457K | ﹤0.01% |
5,526
-131
| -2% | -$8.71K |
|
3220
Afya
AFYA
$1.27B
| $456K | ﹤0.01% |
25,511
+16,241
| +175% | +$297K |
|
3221
PUT
Teva Pharmaceuticals
TEVA
$42.8B
| $454K | ﹤0.01% |
+271
| New | +$4.37K |
|
3222
Columbia Banking Systems
COLB
$9.25B
| $454K | ﹤0.01% |
19,422
-4,523
| -19% | -$105K |
|
3223
International Money Express
IMXI
$441M
| $454K | ﹤0.01% |
44,963
+37,964
| +542% | +$433K |
|
|
INVX
3224
Innovex International
INVX
$2.18B
| $453K | ﹤0.01% |
29,021
+26,566
| +1,082% | +$408K |
|
3225
Crinetics Pharmaceuticals
CRNX
$8.99B
| $453K | ﹤0.01% |
15,755
+5,287
| +51% | +$163K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2025 Portfolio in Review
As of Q2 2025, BNP Paribas Financial Markets held 5,753 positions worth $174B, up 2.6% from $170B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets withdrew a net $17.3B in Q2 2025, closing 319 positions and reducing 2,230 holdings. Its most notable exit was Discover Financial Services, an estimated $106M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, BNP Paribas Financial Markets opened a new position in Gen Digital worth $30.2M.
- BNP Paribas Financial Markets's largest Q2 2025 buy was Gen Digital: 1,027,875 shares worth $30.2M.
- BNP Paribas Financial Markets added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $548M increase.
- BNP Paribas Financial Markets's biggest Q2 2025 reduction was Alibaba, cutting an estimated $852M.
- BNP Paribas Financial Markets fully exited Discover Financial Services in Q2 2025, selling an estimated $106M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $174B portfolio in Q2 2025.
- BNP Paribas Financial Markets opened 373 new positions and closed 319 in Q2 2025.
- BNP Paribas Financial Markets's portfolio value rose 2.6% quarter-over-quarter to $174B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2025, filed 14 Aug 2025.